
    
      To assess the data, including safety profile, of Precedex Intravenous Solution administered
      for "sedation during and after mechanical ventilation in the intensive care setting" in
      pediatric patients under actual medical practice in Japan.

      Maruishi Pharmaceutical Co., Ltd. and Pfizer Japan Inc. will collect 50 subjects each.
    
  